You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. Returning athletes: Seniors — Cam Dufour (A), Evan O’Donnell (A ...

Varjo announced it’s now supporting Quest 3 and Quest Pro for its cloud XR streaming platform ‘Reality Cloud’, which lets professionals stream and share immersive 3D content rendered on ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. Returning athletes: Seniors — Piper Bonnefond (G), Ari Guay (D ...

In 2014, Wyeth received a favorable court ruling that rejected claims that the company made a "reverse payment" to Teva (TEVA) to delay the launch of Effexor XR generic. However, an appeals court ...

In 2014, Wyeth received a favorable court ruling that rejected claims that the company made a "reverse payment" to Teva (TEVA) to delay the launch of Effexor XR generic. However, an appeals court ...

In February, Apple's launch of the Vision Pro headset catapulted the concept of extended reality (XR) into the mainstream. Witnessing individuals seamlessly navigate both the digital and physical ...

Drug maker Lupin on Wednesday said it has launched the generic version of Oracea capsules in the US market. The company said it has launched the medication, indicated for the treatment of ...

Teva conspired to block competition Pfizer Inc.’s subsidiary Wyeth Pharmaceuticals Inc. agreed to pay $39 million to drug purchasers that alleged the manufacturer illegally worked to block generic ...

Wyeth generated annual sales of $4 billion from Effexor XR, its biggest product. In their lawsuit, the plaintiffs alleged they paid artificially higher prices for Effexor XR because Wyeth and Teva ...

Coadministration of dabigatran etexilate with the antiplatelet drug clopidogrel had no effect on dabigratran's anticoagulant activity as measured by ECT, activated partial thromboplastin time ...

The FDA has cleared a prescription mobile app to treat major depressive disorder. The app, called Rejoyn, is intended to be used as an adjunct treatment along with antidepressants and talk therapy.